HomeBest options strategy › LEGN

Best Options Strategy for LEGN

By Dennis Bosmans · Updated 2026-08-14 · 2 min read · Risk disclaimer

Looking for the best options strategy for Legend Biotech Corporation (LEGN)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live LEGN option chain right now, and a simple map from your view on LEGN to the strategy that fits it. Model any of them in the calculator before you trade.

About LEGN

Legend Biotech Corporation (LEGN) is a major company in Biotechnology. Options traders on LEGN tend to watch , since these can drive large moves in the share price.

About Legend Biotech Corporation

Legend Biotech discovers and develops cell therapies focused primarily on cancer treatment. The company's lead product, cilta-cel, is a CAR-T therapy designed to treat multiple myeloma by engineering a patient's own immune cells to recognize and attack cancer cells. Beyond this advanced candidate, Legend maintains a pipeline of earlier-stage CAR-T therapies targeting various cancers including leukemias and solid tumors like gastric, pancreatic, and lung cancers. The company is also exploring next-generation approaches with allogeneic gamma delta CAR-T and CAR-NK cell therapies, which don't require patient-specific customization and are currently in early trials in China.

Legend generates revenue through partnerships with major pharmaceutical companies. Janssen Biotech collaborates on cilta-cel's development and commercialization, while Novartis holds a license for Legend's CAR-T platform targeting delta-like ligand protein 3. The company operates across three primary geographic markets: the United States, China, and Europe. Founded in 2014 and based in Somerset, New Jersey, Legend operates as a publicly traded biopharmaceutical firm dependent on advancing its clinical programs…

Today's top-scoring strategy for LEGN

Our engine ranks defined-risk strategies on the live LEGN chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Iron Condor neutral
Price: $20.20Implied volatility: 32%Expiration: 2026-09-18 (34d)
ActionQtyTypeStrikePremium
BuyPUT$17$0.04
SellPUT$18$0.12
SellCALL$22$0.21
BuyCALL$24$0.02
P/L at expiry vs today At expiry Today ±1σ
$13$21$28
Max Profit
$27
Max Loss
−$173
Net Credit (received)
$27
Breakeven(s)
$17.73, $22.27
Position Greeks
Δ
−8.70
Γ
−15.280
Θ
0.87
ν
−1.87
Time decay (price held)
Implied-volatility skew

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
76%
Mean P/L
$1
Median
$27
Exp. move (1σ)
10%
5th pct
−$132
25th pct
$5
75th pct
$27
95th pct
$27

Strategy analysis

Simulated price paths (time × price)
now $20BE $18BE $22$17$20$240d17d34d
$-171$-73$25

Greeks vs price

Δ — $ P/L per $1 move in the underlying (share-equivalent exposure).
Θ — $ P/L per day from time decay.
ν — $ P/L per +1% in implied volatility.
Γ — how fast delta changes per $1 move.

Price × volatility (today)

−30%−15%IV+15%+30%
$25−$152−$143−$135−$128−$122
$24−$124−$116−$110−$104−$101
$23−$82−$79−$78−$76−$76
$22−$35−$40−$44−$48−$51
$21$1−$8−$16−$23−$30
$20$18$9$0−$8−$17
$19$16$9$1−$6−$13
$18−$4−$8−$12−$16−$20
$17−$35−$33−$33−$33−$33
$16−$61−$57−$53−$51−$49
$15−$71−$69−$66−$64−$61
Analyze LEGN in the calculator → Share this pick ↗

Illustrative example at LEGN's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

LEGN is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.

Options on LEGN currently price in about 32% implied volatility, versus roughly 69% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.

Off that volatility, the options market is pricing a move of about ±$1.98 (±10%) in LEGN by 2026-09-18 — a range of roughly $18.22 to $22.18. Strikes inside that band hold most of the premium and see most of the action.

Across strikes, downside puts on LEGN trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.

LEGN insider trading activity (SEC Form 4)

Open-market insider transactions at LEGN over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.

Open-market buys
0 · —
Open-market sells
2 · $176K
Net (buy − sell)
−$176K
InsiderActionSharesValueDate
Casey Patrick JohnSell6,000$89K2026-06-30
Huang YingSell9,936$87K2026-03-25

Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.

Earnings & IV crush

LEGN's next earnings report is due around November 11, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$3.7B
Beta (vs market)
0.39
52-week range
$16.24–$38.47 (18% up the range)
Short interest
17.3% of float · 5.6 days to cover

With 17.3% of LEGN's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.

How to choose an options strategy for LEGN

Start with your outlook on LEGN, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect LEGN to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect LEGN to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect LEGN to trade in a range

Sell an iron condor to collect premium while LEGN stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

⧉ Embed this free calculator on your site →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open LEGN in the free calculator →

Frequently asked questions

What is the best options strategy for LEGN?

It depends on your outlook. Bullish traders often use a long call or bull call spread on LEGN; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are LEGN options liquid enough to trade?

Legend Biotech Corporation (LEGN) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade LEGN options?

Buying a single LEGN call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade LEGN or any security. Do your own research.

What does Legend Biotech Corporation do?

Legend Biotech Corporation (LEGN) operates in the Biotechnology industry. The "About Legend Biotech Corporation" section above gives a fuller picture of what the company does and how it earns money.

Does Legend Biotech Corporation pay a dividend?

We don't show a confirmed dividend yield for Legend Biotech Corporation here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.

When does Legend Biotech Corporation next report earnings?

Legend Biotech Corporation's next earnings are expected around November 11, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.

Price trend

Short term · 1M
▼ -10.3%
Mid term · 3M
▼ -28.8%
Long term · 1Y
▼ -45.7%

Tickers related to LEGN

Comparing LEGN with similar names can help you choose the best options strategy:

PCVXVaxcyte, Inc.RLAYRelay Therapeutics, Inc.KYMRKymera Therapeutics, Inc.ZLABZai Lab Limited

Company information

Headquarters
2101 Cottontail Lane, Somerset, NJ, 08873, United States
Industry
Biotechnology
Employees
3,100
CEO
Mr. Alan S. Bash
Phone
737 317 5050
Website
legendbiotech.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.